A large GRK2 interactome is emerging, and GRK2 can undergo dynamic regulation via phosphorylation. Protein kinase C (PKC) 10 and c-Src 11 both have been shown to phosphorylate GRK2 under conditions of cellular stress. Moreover, GRK2 has been shown to be phosphorylated by extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) at the specific residue Ser670. 12 Recently, Ser670 also was identified as a site for phosphorylation of GRK2 by phosphoinositide-3-kinase. 13 In addition to phosphorylation-dependent regulation of GRK2, an area suggesting novel roles for GRKs beyond GPCR desensitization is novel subcellular localization of these kinases. For example, we have recently described that GRK5 is targeted to the nucleus of cardiomyocytes, where it acts a novel kinase for class II histone deacetylases, and this activity of GRK5 in the heart influences gene transcription in response to hypertrophic stimuli. 14, 15 Most recently, GRK2 was detected in mitochondria of endothelial cells and human embryonic kidney (HEK) cells, and it had an effect on mitochondrial biogenesis. 16 GRK2 is not targeted to the nucleus of cells; however, in this study, we found that it localizes to heart mitochondria and we have elucidated the signal transduction mechanism that targets GRK2 to mitochondria after oxidative and ischemic stress. We previously reported that GRK2 is a prodeath kinase in the heart, promoting ischemic injury, whereas its inhibition by the peptide inhibitor, carboxyl-terminus of β-adrenergic receptor kinase (βARKct), comprising the carboxyl-terminal domain of bovine GRK2, confers cardioprotection. [17] [18] [19] Specifically, the novel results presented in this study indicate that mitochondrial targeting of GRK2 in myocytes after ischemic injury promotes prodeath signaling because mitochondrial accumulation of GRK2 in myocytes increases after oxidative stress. Preventing this mitochondrial targeting, which can be accomplished with βARKct expression, prevents death signaling and confers cardioprotection. Mechanistically, we found that this novel subcellular localization that occurs after oxidative stress is dependent on ERK-mediated phosphorylation of GRK2 at Ser670, and that the subsequent movement to mitochondria is dependent on binding of phosphorylated GRK2 to Hsp90, a known mitochondrial chaperone. Thus, the data reported herein reveal that mitochondrial-targeted GRK2 is essential for prodeath signaling, occurring after oxidative stress in myocytes, and assigns a novel role for this GRK based on specific ERK regulation and its unique cellular localization.
Methods

Experimental Animals
Cardiac-specific transgenic (TG) mice with GRK2 or βARKct overexpression have been described previously, 19 and for all in vivo experiments nontransgenic littermate control mice were used. All animal procedures were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Temple University School of Medicine.
In Vivo Ischemia/Reperfusion Injury Model
Surgical ischemia/reperfusion (I/R) injury was performed on 8-to 10-week-old mice as previously described. 20 All I/R (30 minutes of ischemia and 30 minutes of reperfusion) procedures were controlled by a sham procedure without coronary ligation. We did not measure area at risk or infarct size in this study, but area at risk of the left ventricular is predicted to be 40% to 50%, and infarct of 30% to 40% of area at risk would be expected. I/R procedures were performed on βARKct TG mice and non-TG littermate control mice. At the end of 30 minutes of reperfusion, the mice were euthanized and the hearts were removed, frozen, and saved for biochemical analysis. The numbers of mice used in a particular experiment are provided in the 
Cell Culture
Neonatal rat ventricular myocytes (NRVMs) were isolated and cultured in HamsF10 as previously described. 17 H9c2 cells, HEK 293 cells, and HeLa cells were cultured in DMEM supplemented with 10% bovine calf serum and penicillin-streptomycin in a humidified chamber with 5% CO 2 at 37°C.
Adenovirus, Plasmids and Transfection
Flag-tagged βARKct (GRK2 amino acids 495-689) was created by polymerase chain reaction amplification using full-length bovine GRK2 in the pRK5 vector as a template and the appropriate primer to introduce an N-terminal flag tag. Inserts were subcloned into the pRK5 vector by standard molecular biology techniques.
Using the Quick-change kit from Stratagene 2 flag-tagged βARKct mutants in plasmid pRK5 were created. Serine 670 was mutated to either alanine (S670A) or aspartic acid (S670D). Similar mutations were made in the full length GRK2 cDNA and adenovirus was prepared following cloning into the appropriate AdEasy vectors according to the manufacturer's instructions (Agilent Technologies). Mutations were confirmed by sequencing. Transient transfections were conducted by using 5 μg plasmid DNA and 10 μg Lipofectamine 2000 (Invitrogen) per 100-mm dish of either HEK293 or HeLa cells. Experiments were conducted on cells 48 hours after transfection. Adenoviral-mediated infections of neonatal rat ventricular myocytes were performed using adeno-green fluorescent protein, adeno-GRK2, adeno-GRK2S670A, and adeno-βARKct at multiplicity of infection of 10 on the day after isolation, and cells were used for experiments 48 hours later. Dr S. Kornbluth at Duke University provided flag-tagged Hsp90, and the glutathione S-transferase-Hsp90 construct was kindly provided by Dr A. Chadli at the Medical College of Georgia.
Electron Microscopy
Immunogold electron microscopy was performed as previously described. 21 Briefly, nontransgenic littermate control or GRK2-TG mice at 5 weeks of age were anesthetized via isoflurane inhalation, and heparin was injected at 50 U per mouse. Hearts were excised and retrogradely perfused with a solution containing 118 mol/L NaCl, 4 
Immunofluorescence
HEK cells seeded onto glass coverslips were cotransfected with plasmids, directing expression of mitochondrial-targeted green fluorescent protein and GRK2. Forty-eight hours after transfection, the cells were fixed in 4% paraformaldehyde for 15 minutes, followed by permeabilization for 5 minutes with 0.1% triton in Dulbecco's phosphate-buffered saline. Cells were briefly washed with Dulbecco's phosphate-buffered saline several times and then blocked 90 minutes using Dulbecco's phosphate-buffered saline containing 1% bovine serum albumin, 0.05% Tween 20. Anti-GRK2 antibody (sc-562; Santa Cruz) was added at 1:200 dilution in blocking buffer and applied for 90 minutes with gentle rocking, which was followed by brief washing and addition of anti-rabbit alexa 594 for 90 minutes. Cells were washed, coverslips were mounted on glass slides, and images were acquired using an Olympus Fluoview FV500 confocal laser scanning microscope.
Mitochondria Isolation From Mouse Hearts and Cells
Mitochondria were prepared from mouse hearts or cells as previously described. 22 Briefly, hearts were minced and resuspended in mannitol sucrose hepes (MSH) buffer (210 mmol/L mannitol, 70 mmol/L sucrose, 5 mmol/L HEPES, pH 7.5) supplemented with 1 mmol/L EDTA, homogenized with a glass/glass dounce homogenizer, and centrifuged at 600g for 10 minutes at 4°C. The supernatant was removed, respun at 600g for 10 minutes, removed, and centrifuged again at 5500g for 20 minutes at 4°C. The mitochondrial pellet was resuspended in fresh MSH buffer without EDTA and centrifuged again at 5500g for 20 minutes. The washed mitochondrial pellet was resuspended in radioimmunoprecipitation assay lysis buffer, if being used for immunoprecipitation experiments, rotated for 1 hour at 4°C, and then centrifuged at 13 000 rpm for 10 minutes at 4°C. The clarified lysate was taken to be the mitochondrial extract and was used for Western blotting or immunoprecipitation. In some cases, the mitochondrial pellet was solubilized directly into Laemmli loading buffer. When mitochondria were made from cells, a 100-mm dish containing ≈5×10 6 cells was used, cells were washed once with Dulbecco's phosphate-buffered saline, scraped into MSH buffer, dounce-homogenized, and processed as described.
Proteinase K Assay
For each experiment, 3 male C57 mice at 12 to 14 weeks old were anesthetized with isofluorane, and the hearts were excised and homogenized in MSH buffer to prepare mitochondria. Mitochondrial exposure to proteinase K was performed with minor modification as previously described. 8 Briefly, 40 μg of mitochondrial protein was incubated on ice for 30 minutes in MSH buffer containing 20 μg/mL proteinase K (Life Technologies). Digestion was stopped by adding phenylmethanesulfonyl fluoride to a final concentration of 2 mmol/L. The mitochondrial pellet was isolated by centrifugation and solubilized directly in Laemmli loading dye and analyzed for GRK2 by Western blot. Control antibody used for the outer membrane was voltage-dependent anion channel (Neuromab N152B/23), and cytochrome c oxidase 5 (Abcam 110263) was used to examine integrity of the inner membrane.
Immunoprecipitations
GRK2 or Hsp90 was immunoprecipitated from heart radioimmunoprecipitation assay lysates, cells, or mitochondrial extracts using anti-GRK2 or anti-Hsp90 antibody from Santa Cruz (sc-562 and sc-13119 for GRK2 and Hsp90, respectively). Control immunoprecipitations were conducted using the same antibodies that were heat-inactivated before use as previously described. 23 Flag-tagged βARKct was immunoprecipitated using Flag M2-agarose conjugate or rabbit polyclonal Flag antibody (Sigma-Aldrich). For immunoprecipitations, 1 mg heart lysate was used and, for cells, clarified radioimmunoprecipitation assay extracts prepared from 5×10 6 cells were used. For mitochondrial IPs, detergent extracts of mitochondria obtained from a single heart or from 5×10 6 cells were used. Lysates were incubated with primary antibody for 2 hours, followed by incubation with protein A/G Plus agarose beads (Santa Cruz) for 90 minutes. Beads were washed 3 times with radioimmunoprecipitation assay, and proteins in the immunocomplex were eluted from the beads by the addition of Laemmli loading buffer and then heated for 5 minutes at 95°C before loading onto Tris-Glycine gels (Invitrogen).
Immunoblotting and Densitometry
After SDS-PAGE and transfer to nitrocellulose membranes, primary antibody incubations were performed overnight at 4°C. Fluorescent secondary antibodies were obtained from either Molecular Probes or Li-Cor. Membranes were scanned with the Odyssey infrared imaging system (Li-Cor), and the densities of target bands were quantified using the application software of the Odyssey infrared imaging system. Target band density was normalized to the appropriate loading control as described in the Figure legends. Primary antibodies used and sources were the following: anti-GRK2 from Santa Cruz and Millipore; anti-GAPDH from Millipore; antivoltage-dependent anion channel from BD Biosciences; anti-Hsp90 from Santa Cruz, BD Biosciences, and Stressgen; anticleaved caspase-3 and anti-MAPK (phospho and total) from Cell Signaling; anti-histidine from Santa Cruz; antiphospho-Ser670-GRK2 from Invitrogen; and anti-Flag from Sigma-Aldrich.
In Vitro Binding Experiments
HeLa cells were transfected either with a control plasmid or with flagtagged Hsp90; after 48 hours, the mitochondrial fraction was prepared. Equal amounts of mitochondria were incubated with purified HIStagged GRK2 (Invitrogen) in binding buffer composed of phosphatebuffered saline with 0.2 mmol/L ATP and rotated for 2 hours at 4°C. The mitochondria were pelleted by centrifugation, washed with phosphatebuffered saline, and resuspended directly in Laemmli loading buffer. Western blots were conducted for flag-Hsp90, HIS-GRK2, and voltagedependent anion channel. In another set of experiments, wild-type and mutant βARKct were transfected into HEK cells and immunoprecipitated from whole-cell lysates using flag antibody. The washed beads containing βARKct were incubated with glutathione S-transferase-Hsp90 in binding buffer composed of phosphate-buffered saline with 1 mmol/L dithiothreitol and 0.5% Tween20, rotated for 2 hours at 4°C, and then the beads were pelleted and washed in the same buffer. The samples were electrophoresed and transferred to membranes for immunoblotting. Western blotting with antiglutathione S-transferase antibody was conducted to determine the amount of Hsp90 bound to βARKct.
Mitochondrial Ca 2+ Uptake Assay
Fluorometric Ca 2+ uptake experiments were performed as previously described. 24 Briefly, 10-to 12-week-old male mice were euthanized via CO 2 inhalation. For each experiment, 3 mice per group were agematched and processed together for the isolation of mitochondria, which provided enough protein to run the uptake assay in triplicate each time. Hearts were excised and placed in a beaker containing buffer A (225 mmol/L mannitol, 70 mmol/L sucrose, 1 mmol/L EGTA, 10 mmol/L HEPES, pH 7.2). Hearts were washed to remove residual blood, and then the atria was removed and frozen for Western blot to confirm transgene overexpression. Ventricles were minced into pieces, put in a beaker with 5 mg protease type XIV (Sigma) in buffer A, and stirred for 7 minutes, and then bovine serum albumin was added at 0.02 g/mL final concentration. The tissue was homogenized with a Teflon-Potter and spun at 1000g for 3 minutes. Supernatant was filtered through a 100-μm mesh, and pellet was rehomogenized in a Teflon-Potter in buffer A, spun at 1000g for 3 minutes, and filtered through a 100-μm mesh. Pellet was discarded and supernatants were spun at 10 733g for 10 minutes. Pellets were combined, resuspended in buffer B (225 mmol/L mannitol, 70 mmol/L sucrose, 10 mmol/L HEPES, pH 7.2), and spun at 10 733g for 10 minutes. Pellet was resuspended in buffer B, and protein content was determined via bicinchoninic acid protein assay. To begin the assay, which was conducted at room temperature, respiration buffer (120 mmol/L KCl, 70 mmol/L mannitol, 25 mmol/L sucrose, 20 mmol/L HEPES, 5 mmol/L KH 2 PO 4 , 0.5 mmol/L EGTA) containing 0.1 μmol/L calcium green 5 N (Invitrogen) was added to a quartz cuvette, and a zero baseline was established. Mitochondria were added at 0.73 mg/ mL, and then 30 μmol/L free calcium was added every 2 minutes. Measurements (excitation-emission at 503-535 nm) were obtained using a Cary Eclipse Fluorescent Spectrophotometer.
Statistics
Data are expressed as mean±SE. Statistical significance was determined by an unpaired t test or ANOVA and Bonferroni test for multiple comparisons using GraphPad Prism software version 5.9. P<0.05 was considered significant.
Results
GRK2 Localizes to Mitochondria and After Myocardial Ischemic and Oxidative Stress There Is Increased Mitochondrial GRK2 Translocation
Recent data from our laboratory have shown GRK2 to be prodeath in the heart after ischemic injury; in pursuit of mechanisms for this prodeath signaling, we found GRK2 to be present in the mitochondrial fraction of neonatal rat ventricular myocyte and hearts ( Figure 1A and 1B ). Importantly, we confirmed this localization using anti-GRK2 and immunogold electron microscopy of cardiac sections where GRK2 is present within mitochondria ( Figure 1C ). This was an unexpected finding because GRK2 has been thought to be primarily cytosolic, especially in the heart where it regulates several GPCRs, including β-adrenergic receptors that are crucial regulators of cardiac function. 1, 2 We also conducted immunofluorescence experiments in HEK cells, looking at the possible A, Ischemia/reperfusion (I/R)-induced GRK2 translocation to the mitochondrial fraction in wild-type mouse hearts. Mitochondrial fractions were prepared from hearts of sham and I/R-treated mice (30 minutes of ischemia and 30 minutes of reperfusion), followed by immunoblotting to determine levels of GRK2. Results were normalized to voltage-dependent anion channel (VDAC), which was used as the loading control. *P<0.05 I/R vs sham (n=3). B, Neonatal rat ventricular myocytes (NRVM) were stimulated for 30 minutes with 10 μmol/L chelerythrine in the absence or presence of N-acetyl-cysteine (NAC; 5 mmol/L, 40 minutes of pretreatment). Mitochondrial fractions were prepared and immunoblotted for GRK2 and VDAC, which was used as the loading control. *P<0.05 (n=4). C, Electron micrographs demonstrating GRK2 immunogold labeling within mouse heart mitochondria. Increased localization is seen in hearts from cardiac-specific GRK2 transgenic (TG) mice compared with normal littermate controls (NLC). Solid black box is a magnified view of the area within the dashed-line box. D, Ca +2 retention capacity of mouse heart mitochondria isolated from GRK2-TG and corresponding NLC mice. Representative tracings from each line show the ability of Ca +2 uptake of mitochondria from repeated challenges before opening of the mitochondrial permeability transition pore (MPTP) occurs. The bar chart shows the quantification of this result, indicating Ca +2 uptake is decreased in cardiac mitochondria from GRK2-TG mice. *P<0.05 GRK2-TG vs NLC (n=3 separate experiments). E, NRVM were treated for 30 minutes with 10 μmol/L chelerythrine in the absence or presence of NAC, and whole-cell lysates were immunoblotted to detect cleaved caspase-3 (CC3). GAPDH was used as the loading control. *P<0.05 (n=3).
colocalization of GRK2 with a mitochondrial-targeted green fluorescent protein marker protein. The merged confocal image in Online Figure I indicates colocalization. Finally, to further explore the localization of GRK2 in mitochondria, we treated isolated mouse heart mitochondria with proteinase K and, after Western blot, we found that GRK2 was nearly completely digested; as an outer membrane positive control, we found that voltage-dependent anion channel also was decreased after treatment, as would be expected. Cytochrome c oxidase 5, a marker for the inner membrane, was not altered, indicating that GRK2 was primarily associated at the outer membrane, at least basally under control conditions (Online Figure II) . Although the functional role of GRK2 in mitochondria is not understood, we found that the mitochondria prepared from the hearts of transgenic mice overexpressing GRK2 specifically in the heart 19 had an increased sensitivity to Ca +2 -induced opening of the mitochondrial permeability transition pore, a key step in oxidative stress-mediated cell injury ( Figure 1D ). As shown in Figure 1D , the Ca +2 retention capacity, up to the point at which further addition of a Ca +2 pulse results in precipitous Ca +2 release because of opening of the mitochondrial permeability transition pore, was decreased by 16.8% in GRK2 transgenic mice (362.98±20.6 for control and 288.96±16.29 nmol Ca 2+ /mg protein for TG; n=3 separate experiments for both groups). The full pathophysiological role for this negative relationship will be further investigated, but as we began to explore whether the unique subcellular localization of this GRK2 was related to its prodeath signaling in myocytes, we found, interestingly, more GRK2 within cardiac mitochondrial preparations after I/R injury in mice ( Figure 1A ). Furthermore, oxidative stress in cultured myocytes after chelerythrine treatment also led to increased mitochondrial GRK2 localization ( Figure 1B ). Importantly, chelerythrine has been shown to induce apoptosis in myocytes through the generation of reactive oxygen species (ROS), and chelerythrine induces apoptosis despite PKC downregulation, suggesting that PKC inhibition is not the mechanism of chelerythrine-induced apoptosis. 25 We confirmed that treatment of cardiomyocytes with 10 μmol/L chelerythrine for 30 minutes led to increased cleaved caspase-3 formation ( Figure 1E ). The chelerythrine-induced mitochondrial localization of GRK2 was inhibited by cellular pretreatment with the antioxidant Nacetyl-cysteine, providing further evidence that apoptosis was dependent on ROS generation ( Figure 1B ). N-acetyl-cysteine also blocked chelerythrine-mediated apoptotic signaling as measured by cleaved caspase-3 levels ( Figure 1E ).
ROS-Mediated Mitochondrial Localization of GRK2 Is Dependent on Hsp90 Binding
The localization of GRK2 to mitochondria was surprising, given that it has no targeting consensus sequence, although it should be noted that ≈50% of all mitochondrial proteins do not have mitochondrial target sequences. Therefore, we hypothesized that an interaction with an intermediate protein could be involved in this mechanism. A potential candidate emerged from known GRK2-interacting proteins. GRK2 has been shown to associate with Hsp90, 8 and this Hsp is known to be associated with mitochondria. 26 Importantly, recent data have shown that mitochondrial association of other kinases, such as Akt 27 and PKCε, 26, 28 is dependent on Hsp90. We found a parallel increase in mitochondrial-localized Hsp90 and GRK2 in mouse hearts after ischemic injury ( Figure  2A ) and in cultured myocytes after chelerythrine treatment ( Figure 2B ). Previously in the human lukemia-60 cell line GRK2 and Hsp90 have been shown to coimmunoprecipitate, and the interaction was blocked by geldanamycin, a known Hsp90 inhibitor. 8 To explore whether this interaction occurs in myocytes after ischemic or oxidative stress, we treated myocytes with chelerythrine without and with pretreatment with geldanamycin. As shown in Figure 2C , we found decreased chelerythrine-stimulated association of both Hsp90 and GRK2 with mitochondria using geldanamycin. We found that GRK2 and Hsp90 associate in whole-cell lysates prepared from myocytes ( Figure 3A , lane 1) and coimmunoprecipitation between these 2 proteins also occurs specifically in mitochondrial preparations ( Figure 3A , lane 2). We also found that GRK2 and Hsp90 can interact and bind directly using a cell free system. We transfected cells either with a control plasmid or with flag-tagged Hsp90, prepared the mitochondrial fraction from each, and then incubated equal amounts of mitochondria with purified 6× HIS-tagged GRK2. In mitochondria prepared from Hsp90-transfected cells, significantly more GRK2 was present compared with control mitochondria ( Figure 3B ). Finally, arguing in favor of a physiological relevance for this interaction, we found that more GRK2 was associated with Hsp90 (via coimmunoprecipitations) in mouse hearts exposed to I/R (30 minutes of ischemia, 30 minutes or reperfusion) injury and in myocytes when oxidative stress was increased by treatment with chelerythrine ( Figure 3C and 3D ).
ERK Phosphorylation of GRK2 Is Essential for Oxidative Stress-Induced Mitochondrial Localization and Apoptosis
In addition to ROS being necessary for enhanced localization of GRK2 to mitochondria after stress (in vivo studies), we explored other downstream mediators of ischemic and oxidative stress using chelerythrine-stimulated myocytes. We focused initial attention on activation of ERK (p42/44 MAPK), because this has been shown to be activated by chelerythrine, 29 and because ERK can phosphorylate GRK2 specifically at residue Ser670 within its carboxyl terminus. 12 When myocytes were treated for 20 minutes with 10 μmol/L chelerythrine, we observed ≈1.5-fold increase in the amount of phosphorylated (ie, activated) ERK (measured as both p-ERK1 and p-ERK2; Figure 4A ), whereas in cells pretreated for 20 minutes with the MEK (the upstream ERK-activating kinase) inhibitor PD98059, chelerythrine-activated ERK was significantly inhibited ( Figure  4A ). Therefore, this pathway downstream of chelerythrinemediated stress is active in myocytes. Importantly, a site-specific antibody that recognizes GRK2 when phosphorylated at Ser670 is available, and we examined whether chelerythrine leads to the phosphorylation of GRK2 at this site in myocytes. These experiments were conducted by immunoprecipitating GRK2 from myocytes and then blotting for pSer670-GRK2. As shown in Figure 4B , the amount of pSer670-GRK2 was increased >2fold after a 20-minute treatment of cells with chelerythrine, and this was significantly decreased in the presence of PD95089.
Similarly, we found that the chelerythrine activation of ERK and the concomitant phosphorylation of GRK2 at Ser670 were blocked by pretreatment of cells with the antioxidant N-acetylcysteine ( Figure 4C ). Based on these experiments, we hypothesized that phosphorylation of GRK2 at Ser670 might regulate stress-induced translocation of GRK2 to mitochondria and cell death. When cardiomyocytes were pretreated with PD98059, we found that the amount of GRK2 that was localized to mitochondria after treatment with chelerythrine, which normally is increased, was significantly decreased, and the proportion of GRK2 that was in the phospho-Ser670 state within the mitochondrial fraction was also decreased compared with cells in which ERK was not inhibited ( Figure 4D ). To strengthen our findings, we used a different cellular model to examine the prodeath capability of GRK2. Accordingly, we found that cells overexpressing the S670A-GRK2 mutant had less H 2 O 2 -induced death as determined by the terminal deoxynucleotidyl transferase dUTP nick end labeling assay. As shown in Online Figure III , myocytes were infected with either wild-type GRK2 or the S670A-GRK2 mutant and then treated with 75 μmol/L H 2 O 2 for 16 hours and processed for terminal deoxynucleotidyl transferase dUTP nick end labeling staining. In cells expressing mutant GRK2, the amount of cell death was significantly reduced by 36.4% (6.38±0.60% for wild-type vs 4.05±0.58% for mutant GRK2). Thus, ERK-dependent phosphorylation of GRK2 is required for its full prodeath capacity.
GRK2-Hsp90 Interaction Is Dependent on GRK2 Phosphorylation at Ser670
Interestingly, we found an ERK dependence on the Hsp90 binding of GRK2, because PD98059 treatment decreased the amount of wild-type GRK2 bound ( Figure 4E ), which parallels the PD98059-induced reduction of GRK2 in mitochondrial fractions after chelerythrine ( Figure 4D ). The directed phosphorylation of GRK2 at Ser670 seems to mechanistically target binding to Hsp90 before mitochondrial localization, because a mutant GRK2 in which Ser670 was replaced by the nonphosphorylated Ala (GRK2-S670A) displayed significantly less Hsp90 binding in myocytes after oxidative stress compared with wild-type GRK2 ( Figure 5A ). Thus, nonphosphorylated GRK2 would not be expected to localize to mitochondria after oxidative stress, which is consistent with less death seen with GRK2-S670A overexpression.
Ser670 resides within the βARKct; thus, we have a powerful molecular tool to further explore the mechanistic role of ERKmediated GRK2 recruitment to mitochondria. This is even more intriguing because myocyte expression of βARKct leads to cardioprotection in vivo after ischemic injury with significantly decreased myocardial apoptotic signaling. 18 Accordingly, using wild-type βARKct as the standard for prosurvival signaling in stressed myocytes, we constructed 2 βARKct mutants, βARKct-S670A and βARKct-S670D, the latter as a potential phosphomimetic mutant of this GRK2 peptide, and studied these in transiently transfected HEK cells. Importantly, we found that wild-type βARKct (flag-tagged) could be immunoprecipitated with Hsp90 in cell extracts, showing that the carboxylterminus of GRK2 directs binding ( Figure 5B ). Furthermore, as with full-length GRK2, chelerythrine treatment resulted in enhanced phosphorylation of the βARKct at Ser670 ( Figure  5C ). However, and as would be predicted, the βARKct-S670A mutant showed no signal with the pSer670 antibody ( Figure  5C ), a result that also documents the specificity of this antibody (the βARKct contains 9 serine residues).
Next, we used an in vitro binding assay to examine whether the phosphorylation of Ser670 influences the Hsp90 and βARKct interaction. Flag-tagged βARKct, βARKct-S670A, or βARKct-S670D was immunoprecipitated from whole-cell extracts, and then purified glutathione S-transferase-Hsp90 was added to these samples. As shown in the Western blot in Figure 5D , βARKct-S670D displayed the highest level of Hsp90 binding, whereas βARKct-S670A was lower compared with wild-type βARKct binding. These results support the hypothesis that phosphorylation at this site places the carboxyl terminus of GRK2 in a configuration that is structurally favorable for binding with Hsp90. Moreover, we found that wildtype βARKct, like GRK2, robustly localizes to mitochondria, and this is increased after chelerythrine treatment; however, βARKct-S670A mitochondrial localization after oxidative stress is significantly impaired ( Figure 5E ). This strongly argues for the importance of ERK phosphorylation of this site on GRK2 to direct Hsp90-dependent mitochondrial translocation. To solidify this mechanism, we found that expression of wild-type βARKct inhibits the stress-induced mitochondrial localization of endogenous GRK2, whereas expression of Figure 3 . G protein-coupled receptor kinase 2 (GRK2) binds to heat shock protein 90 (Hsp90), and this interaction is increased by oxidative stress. A, Hsp90 was immunoprecipitated from neonatal rat ventricular myocyte (NRVM) whole-cell lysates or from purified mitochondrial fractions as indicated followed by immunoblotting for Hsp90 and GRK2 to demonstrate coprecipitation. A representative immunoblot from 3 separate experiments is shown. B, HeLa cells were transfected with flag-Hsp90 vector or empty plasmid as a control, and mitochondrial fractions were prepared and incubated with purified HIS-tagged GRK2 protein to assess in vitro binding of GRK2 to Hsp90. After washing, equal amounts of the mitochondrial pellet were immunoblotted using an antihistidine antibody to detect exogenous GRK2, and a flag antibody was used to detect the transfected Hsp90 in mitochondria. Voltage-dependent anion channel was used as the loading control to which the results were normalized. *P<0.05, GRK2 bound to Hsp90 vs empty vector control (n=3). C, Wild-type mice were exposed to ischemia/reperfusion (I/R) (30 minutes of ischemia and 30 minutes of reperfusion), and then homogenates were prepared using tissue obtained from the ischemic area of the left ventricle. Hsp90 was immunoprecipitated and blotted to detect the amount of GRK2 bound. *P<0.05, I/R vs sham (n=3-4 each group). D, NRVMs were treated for 30 minutes with 10 μmol/L chelerythrine or not treated, and whole-cell lysates were used for Hsp90 immunoprecipitation. The amount of GRK2 coprecipitated was determined by Western blot. A representative immunoblot and quantitation are shown. *P<0.05 chelerythrine vs basal (n=3-4 each group).
βARKct-S670A did not have this effect ( Figure 5F ). The major interpretation of this result is that βARKct competes with GRK2 for Hsp90 binding, and because βARKct-S670A binds less favorably to Hsp90, the inhibition of GRK2 translocation is lost, allowing for the mitochondrial-dependent prodeath activity of the kinase. . Chelerythrine-activated extracellular signal-regulated kinase (ERK) phosphorylates G protein-coupled receptor kinase 2 (GRK2) at serine 670, regulating its heat shock protein 90 (Hsp-90)-dependent mitochondrial translocation. A, Neonatal rat ventricular myocytes (NRVMs) were stimulated for 30 minutes with 10 μmol/L chelerythrine in the absence or presence of PD98059 (30 minutes pretreatment, 50 μmol/L), and whole-cell lysates were analyzed by immunoblotting to detect phospho-ERK and total-ERK. A representative immunoblot is shown along with quantification of the results, which are expressed as fold increase over basal. *P<0.05 (n=3). B, The amount of chelerythrine-induced phosphorylation of Ser670 within GRK2 was analyzed by immunoprecipitating GRK2 from NRVM whole-cell lysates followed by immunoblotting for both p-Ser670 and total GRK2. Pretreatment and stimulation conditions were the same as in (A). The p-Ser670 signal at each condition was normalized to the amount of GRK2 immunoprecipitated. *P<0.05 (n=3). C, NRVMs were stimulated for 30 minutes with 10 μmol/L chelerythrine in the absence or presence of N-acetyl-cysteine (NAC; 5 mmol/L, 40 minutes of pretreatment). Whole-cell lysates were immunoblotted for ERK activation (p-ERK) and phosphorylation status of GRK2 Ser670. *P<0.05 NAC vs control (n=3). D, Mitochondrial fractions were prepared from chelerythrine-treated NRVMs in the absence and presence of pretreatment with the ERK inhibitor, PD98059. Immunoblotting was used to determine the amount of p-Ser670 and total GRK2 in mitochondria. Voltage-dependent anion channel is shown as a loading control, *P<0.05 PD98059 vs DMSO-treated control myocytes (n=3). E, After treatment of NRVMs with chelerythrine, in the presence or absence of pretreatment with PD98059, Hsp90 was immunoprecipitated from whole-cell lysates followed by immunoblotting for Hsp90 and GRK2. A representative immunoblot from 3 separate experiments is shown on the left, with quantitation showing PD98059 pretreatment decreased the amount of GRK2 interacting with Hsp90 shown on right. *P<0.05, PD98059 vs control.
βARKct-Mediated Cardioprotection In Vivo Is Mediated Via Less Mitochondrial GRK2 Localization in Response to ERK Phosphorylation
We have shown that βARKct expression prevents GRK2 mitochondrial localization after oxidative stress in HEK cells, and that this mechanism also robustly occurs in cardiomyocytes ( Figure 6A ). Consistent with our findings in isolated myocytes, this is also the case in the ischemic heart in vivo, because we have found less GRK2 associated with purified cardiac mitochondria after I/R injury in βARKct transgenic mice compared with nontransgenic mice (Figure 6B ). βARKctmediated cardioprotection in ischemic mouse hearts was associated with lower apoptotic signaling, 18 and we found that mechanistically this is attributable to inhibition of GRK2 mitochondrial localization, because we found that the lack of increased mitochondrial GRK2 accumulation after βARKct expression in myocytes exposed to chelerythrine results in significantly lower cleaved caspase-3 protein levels ( Figure  6C) . To bolster the hypothesis that less apoptotic signaling in βARKct-expressing myocytes is attributable to inhibiting GRK2 movement to mitochondria, we found that the βARKct-S670A mutant does not inhibit chelerythrine-mediated caspase-3 activation ( Figure 6D ), which is a parallel finding showing that this mutant βARKct does not block GRK2 mitochondrial translocation ( Figure 5F ).
We also have positively linked ERK-mediated phosphorylation of GRK2 to prodeath signaling and pathophysiology after ischemic stress, because we found that in cardioprotected βARKct TG mice after I/R injury, there is not only less mitochondrial GRK2 ( Figure 6B ) but also significantly less p-Ser670 in the mitochondrial GRK2, despite equal post-I/R cardiac ERK activation ( Figure 7A ). Interestingly, Ser670 of the βARKct transgenic peptide expressed in βARKct transgenic mice was robustly phosphorylated after I/R ( Figure 7A ), suggesting that after ERK activation this peptide binds Hsp90 more strongly and prevents GRK2 from inducing mitochondrial-mediated death. Of further importance to our hypothesis, these results were reproduced in cultured myocytes treated with chelerythrine ( Figure 7B ).
Discussion
Classically, GRKs phosphorylate agonist-occupied 7-transmembrane spanning receptors, known as GPCRs, and initiate an uncoupling process known as desensitization. The desensitization Figure 5 . Mitogen-activated protein kinase-stimulated phosphorylation of carboxyl-terminus of G protein-coupled receptor kinase 2 (GRK2) regulates its binding to heat shock protein 90 (Hsp90) and translocation to mitochondria. A, Neonatal rat ventricular myocytes were infected with adeno-GRK2 or -GRK2 S670A and, after 48 hours, cells were either treated or not treated with 10 μmol/L chelerythrine for 20 minutes, followed by immunoprecipitation of Hsp90 from the whole-cell lysates. Immunoblotting was conducted to determine the amount of GRK2 bound to Hsp90. A representative blot is shown, which was identical in 4 independent experiments. B, Human embryonic kidney (HEK)293 cells were transfected with an empty vector (control) or carboxyl-terminus of β-adrenergic receptor kinase (βARKct) plasmid and, after immunoprecipitation of Hsp90 from whole-cell lysates, the immune complex was blotted to detect βARKct. C, HEK293 cells were transfected with a plasmid containing wild-type βARKct or βARKct-S670A and, after chelerythrine treatment, whole-cell lysates were immunoblotted to determine p-Ser670 (top). The bottom shows equal expression of the wild-type and mutant βARKct protein. Shown is a representative blot of 3 independent experiments with identical results. D, Differential binding of Hsp90 to wild-type βARKct and Ser670 mutants. Corresponding wild-type and mutant βARKcts were immunoprecipitated using flag antibody after cell transfections. The washed beads containing βARKct peptides were incubated with glutathione S-transferase (GST)-Hsp90 and immunoblotted for GST to determine the amount of Hsp90 bound to βARKct. A representative blot from 3 independent experiments is shown (n=3). E, HEK293 cells were transfected with plasmids containing wild-type βARKct or βARKct-S670A mutant, and then stimulated with chelerythrine. Mitochondrial fractions were immunoblotted for flag-βARKct to assess translocation of the wild-type and mutant peptides, and the results were normalized to voltage-dependent anion channel (VDAC). *P<0.05, βARKct-S670A vs wild-type βARKct (n=3). F, HEK293 cells were transfected with plasmids containing wild-type βARKct or βARKct-S670 or an empty plasmid control, and then stimulated with or without chelerythrine. Mitochondrial fractions were prepared and blotted for endogenous GRK2 and VDAC (left) to determine the normalized GRK2 translocated to mitochondria when βARKct peptides were expressed. *P<0.05, βARKct vs control (n=6). mechanism includes targeted binding of β-arrestins to GRKphosphorylated receptors, which blocks G protein activation. However, β-arrestins also direct G protein-independent signaling by recruiting signaling molecules themselves, 30 opening a new area of GPCR signaling that is in addition to the desensitization process. Similarly, evidence is mounting that GRKs can regulate important cellular processes beyond membrane-bound GPCRs, a finding that has gained traction largely as the result of unexpected cellular localization and protein interactions for this family of kinases. Here, we show that GRK2, the most abundant GRK expressed in the myocardium, associates with the outer membrane of mitochondria. The most significant findings from our study are that oxidative stress results in translocation and an increased amount of GRK2 associating with mitochondria, and we have identified the signaling details that account for this previously unexplored cardiac localization. Furthermore, stressed-induced mitochondrial localization of GRK2 in myocytes promotes prodeath signaling, which adds significant new evidence that GRK2 is a key pathological component in the injured heart. For the past 2 decades, we have used various cellular and animal models to show that the increased GRK2 expression found in failing human myocardium 31 is a maladaptive molecular alteration that can occur very acutely after stress. 1, 2 GRK2 is acutely elevated in the myocardium postmyocardial infarction, [32] [33] [34] and elevated GRK2 has been shown to promote myocyte death through apoptotic signaling, although other mechanisms of death, such as necrosis or necroptosis, should not be ruled out. 17 Our current results show that in addition to promoting dysregulation of β-adrenergic receptor signaling in the injured heart, increased GRK2 expression will result in more GRK2 within mitochondria, which seems to be a nodal locale for this kinase in promoting its prodeath activities in the cardiomyocyte after ischemic and oxidative stress.
The discovery of unique cellular localizations and interactomes for a given protein can provide the starting point for the design of studies that could ultimately lead to uncovering new functional roles in cellular signaling. As mentioned, previous studies have found that within the GRK family, certain members have specific cellular localization characteristics. For example, GRK2/GRK3 have been found to be primarily cytosolic enzymes that associate with the sarcolemmal membrane after agonist occupancy of a GPCR, whereas GRK5/GRK6 are more avidly associated with the membrane at all times. 2, 35 However, these previous notions are being challenged and, as an example, GRK5 and GRK6 have a functional nuclear localization signal within their catalytic domains, 36 and GRK5 has been shown to reside in the nucleus of myocytes. 14, 37 This nuclear localization of myocardial GRK5 has uncovered a novel role for this GRK as a class II histone deacetylase kinase, and its enhanced activity in the nucleus can promote maladaptive myocyte hypertrophy and heart failure. 14, 15 Although we do not fully understand why GRK2 is associated with mitochondria under basal conditions, we have found that increased mitochondrial GRK2 promotes mitochondrial permeability transition pore opening to a lower threshold of Ca 2+ , which in itself demonstrates GRK2 promoting an altered mitochondrial phenotype. We have identified in this report that GRK2 has crucial partners that direct its stressinduced translocation to mitochondria, including ERK MAPK and Hsp90. Of note, without phosphorylation of GRK2 after Figure 6 . Carboxyl-terminus of βadrenergic receptor kinase (βARKct) inhibits stress-induced translocation of G protein-coupled receptor kinase 2 (GRK2) to mitochondria and decreases myocyte apoptosis in vitro and in vivo. A, Neonatal rat ventricular myocytes (NRVMs) were infected with either adeno-green fluorescent protein (GFP) or adeno-βARKct and after 48 hours were stimulated with 10 μmol/L chelerythrine for 30 minutes. Mitochondrial fractions were then purified and immunoblotted to detect endogenous GRK2 levels and normalized to voltage-dependent anion channel (VDAC). *P<0.05, βARKct vs GFP (n=3). B, βARKct TG and NLC mice were exposed to sham or ischemia/reperfusion (I/R) procedures (30 minutes of ischemia and 30 minutes of reperfusion), and then mitochondrial fractions were prepared and immunoblotted for GRK2 and VDAC. *P<0.05, βARKct-Tg vs NLC (n=6 in each group). C, NRVMs were infected with adeno-GFP or adeno-βARKct and then treated with 10 μmol/L chelerythrine for 30 minutes. Whole-cell lysates were prepared and immunoblotted to detect cleaved caspase-3 with immunoblotted GAPDH serving as the loading control and normalization. *P<0.05, βARKct vs GFP (n=3). D, Human embryonic kidney (HEK)293 cells were transfected with the indicated plasmids and then treated with 10 μmol/L chelerythrine for 30 minutes. Levels of cleaved caspase-3 and GAPDH were determined by immunoblotting using whole-cell lysates and normalized to immunoblotted GAPDH. *P<0.05 (n=4).
ROS formation by ERK, specifically at Ser670, there is no mitochondrial localization leading to cell death because this modification of GRK2 is required for it to bind to Hsp90, which directs its recruitment to the primary prodeath organelle within myocytes. Hsp90 is one of several Hsps that function as molecular chaperones involved in the assurance of correct target protein folding and assembly and, interestingly, Hsp90 seems to be more discriminating in terms of client interaction. Evidence suggests a preference for interactions with protein kinases, 38 and kinases including Pim-1, 39 Akt, 40 and PKCε 28 bind to Hsp90. Previously, an interaction between Hsp90 and GRK2 was identified with a potential role in the maturation of this kinase. 8 However, our data uncover a second functional outcome of this interaction, and that is mitochondrial targeting, which is consistent with Hsp90 being identified as an important mitochondrial protein in a proteomic analysis of mouse mitochondria. 24 Because most mitochondrial proteins are nuclear-encoded and synthesized in the cytosol, the finding that molecular chaperones Hsp90 and Hsp70 deliver immature proteins to the mitochondrial import receptor Tom70 41 was a key discovery that seems to have broader implications in cellular functions, especially in cardiomyocytes after ischemic stress and this previously unappreciated mechanistic role for GRK2. Interestingly, Hsp90 also can play a critical role in cell survival by binding to components of the permeability transition pore and antagonizing its opening, thus preserving organelle integrity and inhibiting the onset of cell death. 42, 43 Our data suggest that in myocytes there seems to be a more complex relationship between Hsp90 and mitochondrial-mediated death, because the ROS-induced increased localization of GRK2 to mitochondria is associated with increased death signaling. Future studies that are beyond the scope of the present study will examine whether GRK2 specifically antagonizes the prosurvival effects of Hsp90 in mitochondria, because this could occur through a direct inhibition or perhaps GRK2 can antagonize the antideath effects of other known Hsp90 binding partners in the heart.
The mitochondrial uptake of several cardioprotective proteins, including connexin, Akt, and PKCε, has been shown to entail Hsp90-mediated import. 27, 28, 44, 45 Interestingly, a previous study in liver endothelial cells has shown that when GRK2 is elevated it binds to and inhibits Akt in the cytoplasm, 7 suggesting the potential for this interaction to take place at the level of Hsp90 binding or perhaps at mitochondria. Certainly, our mitochondrial-dependent prodeath signaling ascribed to GRK2 in this study is consistent with potential antagonism Figure 7 . Ischemic and oxidative stress-induced extracellular signal-regulated kinase (ERK) phosphorylation of G proteincoupled receptor kinase 2 (GRK2) is decreased in the presence of carboxyl-terminus of β-adrenergic receptor kinase (βARKct) in vitro and in vivo. A, After ischemia/reperfusion (I/R) conducted on NLC or βARKct transgenic (TG) mice, hearts were removed and tissue lysates were prepared from the ischemic area of the left ventricular (LV) area or, in the sham group, from the LV area at risk. Immunoblotting was conducted for the indicated proteins, and this representative blot indicates a reduction in p-Ser670 phosphorylation within GRK2 and a parallel increase in p-Ser670 within the βARKct. *P<0.05, GRK2 p-Ser670 levels in βARKct post-I/R mice versus NLC post-I/R mice (n=5 mice per groups). B, Neonatal rat ventricular myocytes were infected with adeno-green fluorescent protein (GFP) or adeno-βARKct and, 48 hours later, were treated for 20 minutes with 10 μmol/L chelerythrine. Whole-cell lysates were then prepared and blotted for the indicated proteins shown on the representative blot. Cells expressing βARKct had significantly less pSer670 levels in endogenous GRK2 compared with GFP-expressing cells. *P<0.05 GRK2 p-Ser670 levels in βARKct-infected myocytes compared with GFP-infected myocytes (n=3).
of the prosurvival effects of Akt, and although we did not specifically find a direct interaction between these 2 kinases in mitochondrial fractions of myocytes, it is possible that the prodeath effects of GRK2 in ischemic myocytes opposes any benefit of Akt within mitochondria. Interestingly, in cardiomyocytes, Akt also was shown to phosphorylate mitochondrial hexokinase, a mitochondrial outer membrane protein, and to protect mitochondria from oxidant or calcium-induced stress. 46 Further studies will be conducted to identify any potential substrates for GRK2 within mitochondria.
In addition to Hsp90 being required for mitochondrial localization of GRK2, we found that an absolute requirement was the ERK-mediated phosphorylation of GRK2 at Ser670 because the phosphorylation status at this site was a key determinant of Hsp90 binding and subsequent mitochondrial accumulation. This ascribes a specific and critical role for the regulation of GRK2 by this MAPK within cardiomyocytes and death signaling. Previous studies have shown that phosphorylation of GRK2 by ERK at Ser670 is involved in protein stability and promoted degradation of this kinase. 12, 47 Similarly, this seems to be the case for the homologous GRK3 after ERK phosphorylation. 48 A more recent study has shown that Ser670 phosphorylation by the cell-cycle kinase, CDK2, may be more crucial for GRK2 degradation within its context as a cell-cycle regulator. 49 Furthermore, in neuronal cells, phosphorylation of GRK2 at Ser670 by phosphoinositide-3-kinase promoted degradation. 13 Thus, although Ser670 may be the key target to promote GRK2 degradation, differential regulation seems to occur via specific kinases, and our data would suggest that ERK-mediated Ser670 phosphorylation targets GRK2 to mitochondria. Importantly, targeting of GRK2 to mitochondria after this phosphorylation event would result in a subsequent loss of cytoplasmic GRK2 consistent with degradation; however, without knowledge of the unique cellular localization of GRK2 uncovered in our report, this aspect of GRK2 regulation was not studied. A number of studies indicate that activation of the reperfusion injury salvage kinase pathway at the time of injury is cardioprotective. 50 ERK1/2 is one of the kinases involved in this pathway; in these studies, the beneficial effects of ERK were identified based on the finding that administration of growth factors or other agents at the time of reperfusion resulted in protection through phosphorylation and inhibition of proapoptotic proteins. In contrast to the signals triggered by administration of growth factors, ischemic stress activates a different repertoire of signaling molecules, and the final cellular response derives from the integration of beneficial and prodeath signals. In our study, we show ERK activation being involved in the prodeath mechanism of GRK2; however, this finding should not be interpreted as negating other protective aspects of ERK in accordance with the reperfusion injury salvage kinase hypothesis.
A recent study demonstrated mitochondrial localization of GRK2 in HEK and endothelial cells, and mitochondria with decreased GRK2 had less ATP production, suggesting that increased GRK2 is beneficial. 16 Using GRK2 truncation mutants, it was reported that the amino-terminus of GRK2 associated with mitochondria, but that the carboxyl-terminus did not. We focused on the carboxyl-terminus because it contains the essential serine residue that, when phosphorylated, regulates its interaction with Hsp90. It is possible that multiple domains within GRK2 could regulate association with mitochondria, such as during basal or oxidative stress conditions; however, given the absence of a mitochondrial targeting sequence within GRK2, the lack of mechanistic detail regarding how GRK2 associates with mitochondria through the amino-terminus of the protein is a limitation of their study. Alternatively, cardiac mitochondrial targeting could be different. An important difference between our studies is that we show that increased GRK2 localized to cardiac mitochondria is a damaging phenotype and we provide mitochondrial Ca 2+ uptake data to support this. Our data are also consistent with the physiological evidence that we and others have published showing that increased GRK2 levels in the heart are deleterious in the context of ischemic stress.
There are several potential limitations of our study. We measured I/R-induced (30 minutes of each) translocation of GRK2 to mitochondria and the signaling mechanisms involved, but we did not measure infarct size in a similarly treated cohort; therefore, we were not able to correlate myocardial injury with translocation of GRK2 to mitochondria. However, using the same I/R injury model, GRK2-TG mice had significantly greater 24hour infarcts compared with non-TG littermate control mice. 17 Furthermore, although the mechanism of cell death in mouse models of ischemic injury, such as I/R, remains controversial, it is likely that both apoptosis and necrosis are involved; however, in this study, we focused only on apoptotic signaling. We focused on apoptosis because a previous study 17 reported that mice subjected to 30 minutes of ischemia and 3 hours of reperfusion had increased ventricular caspase-3 activity, which is indicative of apoptosis, and the cell death mechanisms in our study likely would be similar to those reported in that study. Accordingly, we treated neonatal rat ventricular myocytes with chelerythrine, which also increased caspase-3 activity, as a model to study the biochemical signaling pathways that would be activated during in vivo injury in the mouse heart. There could be differences in the relative contribution that apoptosis and necrosis play in adult compared with neonatal myocytes exposed to ischemic stress. For example, one study reported that isolated adult myocytes exposed to 6 hours of hypoxia and 6 hours of reperfusion had increased cytochrome C release and caspase activity compared with control cells, 51 which supports apoptotic mechanisms in the adult cell. However, a different study showed changes in the level of proteins important in the assembly and formation of the apoptosome in adult compared with neonatal myocytes, supporting the view that adult myocytes are more resistant than neonatal myocytes to mitochondrial-driven apoptosis. 52 Thus, the relationship between apoptosis and necrosis and the relative importance of each in neonatal and adult cell death during I/R injury continue to evolve, and future studies will help resolve these controversies.
Of potential therapeutic importance, our current data assign a new beneficial mechanism for the action of βARKct in the injured heart as sequences within this peptide direct phosphorylation-dependent binding to Hsp90, and the binding of this expressed and phosphorylated peptide blocks endogenous GRK2 binding to Hsp90 and subsequent mitochondrial localization preventing GRK2-mediated prodeath signaling. We have recently shown that βARKct expression in the infarcted heart significantly reduces cellular apoptosis; in this study, we found that Ser670 is critical for βARKct-mediated cardioprotection, because we discovered that prodeath signaling after oxidative stress in myocytes was not blocked by a βARKct mutant that lacks the ERK phosphorylation site. This nonprotective βARKct mutant does not seem to prevent endogenous GRK2 from binding to Hsp90, thus GRK2 is free to translocate to the mitochondria and promote caspase activation.
In conclusion, our study is the first to report cellular association of GRK2 with mitochondria of cardiomyocytes, and that this localization increases on ischemic and oxidative stress, events that promote its prodeath signaling. These findings add significant mechanistic information for the maladaptive effect of GRK2 that occurs within the compromised myocardium. Importantly, we ascribe a novel regulatory feature to Ser670 within the carboxyl terminus of GRK2 in that after ROSdependent ERK phosphorylation, there is increased binding to Hsp90 and subsequent translocation to mitochondria. Our results are clear that ERK phosphorylation and Hsp90-dependent mitochondrial localization of GRK2 in ischemic cardiomyocytes promote non-GPCR-mediated prodeath effects of this GRK. This is an apparent key role for GRK2 in the pathogenesis of heart failure and increases the therapeutic importance of GRK2 inhibition as a strategy to combat heart disease.
